1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Depomed, Inc. - Strategy and SWOT Report

Depomed, Inc. - Strategy and SWOT Report

  • November 2015
  • -
  • MarketLine
  • -
  • 29 pages

Introduction

Depomed, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Features:

- Detailed information on Depomed, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Depomed, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Depomed, Inc. including a breakdown and examination of key business segments

- Intelligence on Depomed, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Depomed, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Depomed, Inc. (Depomed or 'the company') is a specialty pharmaceutical company focused on pain and other central nervous system (CNS) conditions. The company primarily operates in the US. Depomed is headquartered in Menlo Park, California, and employed 324 people as on December 31, 2014. The company recorded revenues of $390.4 million during the financial year ended December 2014 (FY2014), as compared to $134.2 million in FY2013. The operating profit of the company was $236.8 million in FY2014, as compared to an operating profit of $9.3 million in FY2013. The net profit of the company was $131.8 million in FY2014, as compared to a net profit of $43.3 million in FY2013.

Reasons to Purchase:

- Gain understanding of Depomed, Inc. and the factors that influence its strategies

- Track strategic initiatives of the company and latest corporate news and actions

- Assess Depomed, Inc. as a prospective partner, vendor or supplier

- Support sales activities by understanding your customers' businesses better

- Stay up to date on Depomed, Inc.’s business structure, strategy and prospects

Table Of Contents

Depomed, Inc. - Strategy and SWOT Report
Company Overview
Business Description
History
Key Employees and Biographies
Company View
Locations and Subsidiaries
SWOT Analysis
Revenue Analysis
Key Competitors
Major Products and Services

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Pipeline Review, H2 2016

Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Nociceptin Receptor (Kappa Type 3 Opioid Recepto ...

Acute Pain - Pipeline Review, H2 2016

Acute Pain - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Acute Pain - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Acute Pain - Pipeline Review, H2 2016’, provides an overview of the Acute Pain pipeline landscape. The report provides comprehensive ...

Cancer Pain - Pipeline Review, H2 2016

Cancer Pain - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cancer Pain - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain – Pipeline Review, H2 2016, provides an overview of the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.